Compare Inovio Pharmaceuticals Inc (INO) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Recursion Pharmaceuticals Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 17.1× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | RXRX | |
|---|---|---|
Market Cap | $89.27M | $1.53B |
Sector | Health | Health |
52-Week High | $2.87 | $6.79 |
52-Week Low | $1.05 | $2.84 |
Enterprise Value | $60.28M | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
